Physician profile
Heather Driessen
NPI 1568602589
$3,293.89
in general payments reported to CMS, 2019-2025
28 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,015 · 2020: $328 · 2021: $96.32 · 2022: $339 · 2023: $1,151 · 2024: $218 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043 · Travel and Lodging: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.86 |
| Travel and Lodging | $472.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,308.99 | 2019-2025 | Puraply, Via Matrix, Novachor |
| Treace Medical Concepts, INC. | $866.91 | 2020-2023 | |
| Convatec INC. | $157.99 | 2023 | |
| Celularity INC. | $118.00 | 2019 | |
| Horizon Therapeutics Plc | $106.78 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $101.49 | 2022-2023 | Bone Anchors With Arthroscopic Delivery System, Grafix Pl, Oasis |
| Amgen INC. | $74.72 | 2024 | Krystexxa |
| Integra Lifesciences Corporation | $66.05 | 2019-2020 | |
| Averitas Pharma INC. | $65.34 | 2023-2025 | Qutenza |
| Inari Medical, INC. | $52.59 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbvie INC. | $39.52 | 2022-2023 | Dalvance |
| Nevro Corp. | $30.33 | 2024 | Senza |
| Nabriva Therapeutics, Plc | $28.34 | 2020-2021 | |
| Gilead Sciences, INC. | $27.98 | 2025 | |
| Depuy Synthes Sales INC. | $26.44 | 2023 | Na, N/A |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $24.52 | 2022 | |
| Paratek Pharmaceuticals, INC. | $23.84 | 2024 | Nuzyra |
| Ermi LLC | $21.70 | 2020 | |
| Stryker Corporation | $21.07 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $16.83 | 2019 | |
| Triad Life Sciences INC. | $16.40 | 2022 | |
| Kerecis Limited | $16.25 | 2021 | |
| Bioventus LLC | $15.27 | 2024 | Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $15.05 | 2023 | Intellis Adaptivestim |
| Sebela Pharmaceuticals INC. | $13.99 | 2019 | |
| Cashflow Solutions, LLC | $13.19 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Kowa Pharmaceuticals America, INC. | $12.88 | 2023 | Seglentis |
| Paragon 28, INC. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Driessen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.